Capsule Summary Slidesets

Share

Program Content

Activities

  • DISCOVER
    DISCOVER: Phase III Study of Emtricitabine/Tenofovir Alafenamide vs Emtricitabine/Tenofovir Disoproxil Fumarate for HIV PrEP
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 11, 2019

    Expires: March 09, 2020

  • PrEP and Drug Resistance
    Effects of PrEP on Drug Resistance and Acute HIV Infection in New York City Surveillance Population
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 11, 2019

    Expires: March 09, 2020

  • ATLAS
    ATLAS: Week 48 Results From Phase III Study of Switching to Long-Acting Cabotegravir + Rilpivirine in Virologically Suppressed Patients With No Prior Virologic Failure
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 09, 2019

    Expires: March 07, 2020

  • FLAIR
    FLAIR: Switch to Long-Acting CAB + RPV Following Oral Induction in ART-Naive Patients Noninferior to Continued DTG/ABC/3TC at Week 48
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 11, 2019

    Expires: March 09, 2020

  • DAWNING
    DAWNING: High Virologic Response Rates at Week 48 With DTG-Based ART Regardless of Baseline NRTI RAMs and Second-Line NRTI Use
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 13, 2019

    Expires: March 11, 2020

  • Opioid Overdose Deaths in HIV
    Increased Deaths From Opioid Overdose Among Persons With HIV Infection, 2011-2015
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 11, 2019

    Expires: March 09, 2020

  • HPTN 077
    HPTN 077: No Significant Weight Gain at Week 41 With Long-Acting CAB vs PBO in HIV-Uninfected Persons at Low Risk for Infection
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 11, 2019

    Expires: March 09, 2020

  • NICHD P1081
    NICHD P1081: Improved Virologic Suppression at Delivery With RAL- vs EFV-Based ART in Pregnant Women With HIV Infection
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 07, 2019

    Expires: March 05, 2020

  • DolPHIN-2
    DolPHIN-2: More Rapid Virologic Suppression With DTG- vs EFV-Based ART Initiated in Late Pregnancy
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 08, 2019

    Expires: March 06, 2020

  • Study 380-1474
    GS-US-380-1474: Switch to BIC/FTC/TAF Safely Maintains Virologic Suppression at Week 48 in Children and Adolescents With HIV Infection
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 11, 2019

    Expires: March 09, 2020

Provided by

ProCE Banner

Supporters

Gilead

Gilead Text

Janssen

Merck Human Health HIV

ViiV Healthcare